IARC Again Asked to Review RF Cancer Risk, Just Not Right Away
An advisory group to the International Agency for Research on Cancer (IARC) has —once again— recommended a new assessment of the cancer risk posed by RF radiation. RF is one of about a hundred agents listed as “high priority” for evaluation over the next five years, 2025-2029.
The panel, made up of 28 independent scientists from 22 countries, met last month in Lyon, France (IARC’s hometown), to consider more than 200 agents that had been nominated for evaluation or reevaluation. The panel’s recommendations were announced yesterday in the news section of Lancet Oncology and an IARC press release.
Sign up for free news and updates from Children’s Health Defense. CHD focuses on legal strategies to defend the health of our children and obtain justice for those injured. We can't do it without your support.